Literature DB >> 3380600

Hypoxic arousal responses in infants with bronchopulmonary dysplasia.

M Garg1, S I Kurzner, D Bautista, T G Keens.   

Abstract

Infants with bronchopulmonary dysplasia have a high incidence of sudden, unexplained death in the postneonatal period, yet the cause of these deaths is unknown. Frequent episodes of clinically unsuspected arterial oxygen desaturation have recently been described in infants with bronchopulmonary dysplasia. We hypothesized that infants with bronchopulmonary dysplasia who experience frequent episodes of hypoxia may have abnormal arousal responses to these hypoxic episodes. We studied 12 infants with bronchopulmonary dysplasia at 41.4 +/- 1.3 weeks postconceptional age. Hypoxic arousal responses were performed during quiet sleep at an inspired oxygen tension of 80 mm Hg for a maximum of three minutes or until arousal occurred. Of 12 infants, 11 (92%) aroused normally to the hypoxic challenge. However, all infants required vigorous stimulation and supplemental oxygen after the initial arousal response. Of 12 infants with bronchopulmonary dysplasia, eight (67%) experienced prolonged apnea with bradycardia, and four of 12 (33%) required brief ventilatory assistance (bag and mask) to restore normal breathing. Abnormal pneumographic findings did not predict the occurrence of these prolonged periods of apnea and bradycardia following hypoxia. We conclude that an abnormal response to hypoxia following arousal may lead to prolonged apnea and bradycardia in infants with bronchopulmonary dysplasia. We speculate that the inability to recover from this hypoxia may result in sudden death in these infants.

Entities:  

Mesh:

Year:  1988        PMID: 3380600

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

Review 1.  A risk-benefit assessment of drugs used for neonatal chronic lung disease.

Authors:  D G Sweet; H L Halliday
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

Review 2.  Ventilatory control in infants, children, and adults with bronchopulmonary dysplasia.

Authors:  Melissa L Bates; De-Ann M Pillers; Mari Palta; Emily T Farrell; Marlowe W Eldridge
Journal:  Respir Physiol Neurobiol       Date:  2013-07-22       Impact factor: 1.931

3.  Blunted hypoxic pulmonary vasoconstriction in experimental neonatal chronic lung disease.

Authors:  Gloria Juliana Rey-Parra; Stephen L Archer; Richard D Bland; Kurt H Albertine; David P Carlton; Soo-Chul Cho; Beth Kirby; Al Haromy; Farah Eaton; Xichen Wu; Bernard Thébaud
Journal:  Am J Respir Crit Care Med       Date:  2008-05-29       Impact factor: 21.405

4.  Development of peripheral chemoreceptor function in infants with chronic lung disease and initially lacking hyperoxic response.

Authors:  M Katz-Salamon; M Eriksson; B Jónsson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-07       Impact factor: 5.747

5.  Bronchopulmonary dysplasia: a longitudinal study of 23 cases.

Authors:  I Lambert; T G Matthews; T A Clarke
Journal:  Ir J Med Sci       Date:  1991-10       Impact factor: 1.568

6.  Parental Insights into Improving Home Pulse Oximetry Monitoring in Infants.

Authors:  Daria F Ferro; Christopher P Bonafide; Nicole Fregene; Halley Ruppel; Maria N Nelson; Whitney Eriksen; Sara B DeMauro
Journal:  Pediatr Qual Saf       Date:  2022-03-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.